Publications by authors named "Yann Le Goff"
Article Synopsis
- The study examines current practices with long half-life lipoglycopeptides (LGPs), particularly oritavancin, and how they're mainly used off-label for bone and joint infections (BJIs) and infective endocarditis despite being approved only for skin and soft tissue infections (SSTIs).
- Oritavancin, along with dalbavancin, is notable for its one-time dosing, with oritavancin potentially offering advantages for shorter treatment durations (less than 2 weeks) and various infections like urinary tract infections and catheter-related infections.
- The findings suggest that LGPs, such as oritavancin, are changing treatment approaches for acute bacterial infections and may
Introduction: Bladder cancer is currently ranked as the 8th most common cancer in France. However, the patient care pathway for this cancer is still not well known.
Methods: A telephone survey was conducted with fifteen healthcare professionals, ten patients, and five family caregivers between November 2020 and March 2021.
Objective: To compare two different techniques of percutaneous tracheostomy: Griggs' forceps-dilational technique and Fantoni's translaryngeal technique, both performed with the manufacturer's basic kit and with bronchoscopic guidance.
Design: A prospective, randomized trial was designed to compare the two tracheostomy techniques. Critically ill patients requiring elective tracheostomy for long-term ventilation were randomized for translaryngeal tracheostomy or forceps-dilational tracheostomy.